UFP Technologies, Inc.

Good day and welcome to the USPT second quarter 2026 earnings call and webcast conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To withdraw your question, please press star then two. Please note this event is being recorded. I would now like to turn the conference over to Ron Lataille, Chief Financial Officer. Please go ahead.

Thank you, operator. Good morning and thank you for joining us on our 2026 Second Quarter Earnings Conference Call. With me on today's call is our President and CEO, Mitch Rock. Today, we will make some forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 the accuracy of which is subject to risks and uncertainties. Wherever possible, we will try to identify those forward-looking statements by using words such as believe, expect, anticipate, pursue, forecast, and similar expressions. Our forward-looking statements are based on our estimates and assumptions as of today and should not be relied upon as representing our estimates or views on any subsequent date. Please refer to the cautionary statement regarding forward-looking information and the risk factors in our most recent 10 and 10 , including disclosure of the factors that could cause results to differ materially from those expressed or implied. During this call, we will discuss non-GAAP financial measures, which include organic sales growth, adjusted operating income, adjusted SG&A, adjusted EPS, and adjusted EBITDA. A reconciliation of GAAP to non-GAAP measures discussed in this call is contained in the associated press release and is available in the investor relations section of our website. I'll now turn the call over to Mitch.

Good morning everyone and thank you for joining us. Before discussing the quarter, I want to briefly acknowledge my first earnings call as President and Chief Executive Officer of UFP Technologies. Having spent many years helping build the company and the platform we operate today, I view this transition as a continuation of the strategy that has driven our success. Our priorities remain unchanged, supporting our customers, investing in our team and capabilities, pursuing disciplined acquisitions, and creating long-term value for shareholders. Our second quarter and first half results reflect solid execution across the platform and continued progress towards our long-term growth strategy. During the second quarter, sales increased 15.1% to $174 million. Gross margins increased to 29.3%. and operating income grew 15.5%. We also delivered adjusted earnings per share growth of 16.8% to a company record of $2.92. These results were driven by contributions across the UFP platform and demonstrate the strength and diversity of our MedTech business. Growth remained broad-based throughout the portfolio with our top five customers growing 14.7%, while the balance of our MedTech business grew 19.7%. One of the most important aspects of the quarter is that growth was not dependent on any single customer, product category, or end market. Rather, performance was driven by a diverse set of customer programs, the breadth of our businesses, and the continued execution of our teams across the organization. We continue to invest in the Dominican Republic to support customer driven growth initiatives, expand capacity and enhance our cost structure over time. These investments are generating early operational benefits and strengthening our ability to support future growth. While the full realization of those benefits is taking longer than originally anticipated, we remain confident in the long-term value of these investments and the opportunities they create for our customers and our business. We also continue to strengthen our organization during the quarter. Recent additions in business development, operations, and legal increased our leadership capacity and support our next phase of growth. As we grow with existing customers, launch new programs and evaluate acquisition opportunities, we believe investing in organizational capacity is just as important as investing in facilities and equipment. These investments also position us to onboard additional companies into our decentralized operating model as we continue to expand the platform. Our acquisition strategy remains unchanged and our pipeline of opportunities is robust. We continue to evaluate businesses that can expand our capabilities and strengthen our position in attractive medtech markets. As always, we remain disciplined in our evaluation approach and committed to deploying capital in ways that create long-term shareholder value. Looking ahead, We continue to see meaningful opportunities to grow with existing customers, support new program launches, pursue discipline on acquisitions, and invest in our people and capabilities. We believe the combination of our customer relationships, manufacturing footprint, robust acquisition pipeline, and strengthened leadership team position us well for continued growth. The markets we serve remain attractive, our customer relationships remain strong, and we remain focused on discipline execution and long-term value creation for our customers and shareholders. Most importantly, I want to thank our team members around the world for the continued dedication to our customers and each other, their commitment, expertise, and execution remain the foundation of UOP's success as we enter the next chapter of the company's growth. With that, I'll turn the call over to Ron to review our financial results in greater detail.